In a search for an explanation of the negative results of HGF/MET inhibitors, it was considered whether MET expression by IHC is a true indicator of the efficacy of MET/HGF inhibitors and whether there is heterogeneity of MET expression in GC tissues. The gene discussed is HGF; the disease is gastric cancer.